680
PUBLIC LAW 92-423-SEPT. 19, 1972
[86 STAT.
(6) blood and blood products are essential human resources whose value in saving life and promoting health cannot be assessed in terms of dollars; (7) the provision of prompt and effective emergency medical services utilizing to the fullest extent possible advances in transportation and communications and other electronic systems and specially trained professional and paraprofessional health care personnel can reduce substantially the number of fatalities and severe disabilities due to critical illnesses in connection with heart, blood vessel, lung, and blood diseases; and (8) the greatest potential for advancement against heart, blood vessel, lung, and blood diseases lies in the National Heart and Lung Institute, but advancement against such diseases depends not only on the research programs of that Institute but also on the research programs of other research institutes of the National Institutes of Health. (b) It is the purpose of this Act to enlarge the authority of the National Heart and Lung Institute in order to advance the national nttack upon heart, blood vessel, lung, and blood diseases. JIEAKT, BLOOD VE8SKI., 1A^N(}, AND BLOOD DISEASE PR0<iRAMS
62 Stat. 464. 42 USC 287.
SEC. 8. Part B of title IV of the Public Health Service Act is amended (1) by redesignating section 418 as section 419A. (2) by redesignating section 414 as section 418, and (3) by adding after section 412 the following new sections: " N A T I O N A L H E A R T, BLOOD VESSEL, LUN(}, AND BLOOD DISEASE PROGRAM
NiH, coordination provisions.
"SEC. 413. (a) The Director of the Institute, with the advice of the Council, shall develop a plan for a National Heart, Blood Vessel, Lung, and Blood Disease Program (hereafter in this part referred to as the 'Program') to expand, intensify,"and coordinate the activities of the Institute respecting heart, blood vessel, lung, and blood diseases (including its activities under section 412) and shall carry out the Program in accordance with such plan. The Program shall be coordinated with the other research institutes of the National Institutes of Health to the extent that they have responsibilities respecting such diseases and shall provide for— "(1) investigation into the epidemiology, etiology, and prevention of all forms and aspects of heart, blood vessel, lung, and blood diseases, including investigations into the social, environmental, behavioral, nutritional, biological, and genetic determinants and influences involved in the epidemiology, etiology, and prevention of such diseases; " (2) studies and research into the basic biological processes and mechanisms involved in the underlying normal and abnormal heart, blood vessel, lung, and blood phenomena; "(3) research into the development, trial, and evaluation of techniques, drugs, and devices (including computers) used in, and approaches to, the diagnosis, treatment (including emergency medical service), and prevention of heart, blood vessel, lung, and blood diseases and the rehabilitation of patients suffering from such diseases; ,.,
�
